ADAR1 Capital Management Issues Open Letter to Keros Therapeutics Stockholders ...Middle East

PR Newswire - News

Announces Intention to Withhold Votes for Directors Dr. Mary Ann Gray and Dr. Alpna Seth AUSTIN, Texas, May 8, 2025 /PRNewswire/ -- ADAR1 Capital Management, LLC (together with its affiliates, "ADAR1"), the largest stockholder of Keros Therapeutics (Nasdaq: KROS) ("Keros" or the...

    Read More Details
    Finally We wish PressBee provided you with enough information of ( ADAR1 Capital Management Issues Open Letter to Keros Therapeutics Stockholders )

    Also on site :